Polymyxin B hemoperfusion in sepsis: Growing body of evidence and occasional conflicting results

Blood Purification

Volumn 39, Issue 1-3, 2015, Pages I-II

  Antonelli, Massimo ^a   Ronco, Claudio ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAN BORTOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; POLYMYXIN B;

FEMALE; HEMOPERFUSION; HUMAN; MALE; PERITONITIS; PROCEDURES; SHOCK, SEPTIC;

ANTI-BACTERIAL AGENTS; FEMALE; HEMOPERFUSION; HUMANS; MALE; PERITONITIS; POLYMYXIN B; SHOCK, SEPTIC;

EID: 85027951185     PISSN: 02535068     EISSN: 14219735     Source Type: Journal    
DOI: 10.1159/000431018     Document Type: Editorial

References (10)

1. Ronco C: The place of early haemoperfusion with polymyxin B fibre column in the treatment of sepsis. Crit Care 2005; 9: 631-633.
2. Berto P, Ronco C, Cruz D, Melotti RM, Antonelli M: Cost-effectiveness analysis of polymyxin- B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy. Blood Purif 2011; 32: 331-340.
3. Cruz DN, Perazella MA, Bellomo R, de Cal M, Polanco N, Corradi V, Lentini P, Nalesso F, Ueno T, Ranieri VM, Ronco C: Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 2007; 11:R47.
4. Cruz DN, Bellomo R, Ronco C: Clinical effects of polymyxin B-immobilized fiber column in septic patients. Contrib Nephrol 2007; 156: 444-451.
5. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, Rottoli F, Giunta F, Ronco C: Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009; 301: 2445-2452.
6. Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, Pottecher J, Joannes- Boyau O, Martin-Lefevre L, Jabaudon M, Mimoz O, Coudroy R, Ferrandière M, Kipnis E, Vela C, Chevallier S, Mallat J, Robert R; ABDOMIX Group: Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med 2015, DOI: 10.1007/s00134-015-3751-z.
7. Antonelli M, Fumagalli R, Cruz DN, Brienza N, Giunta F; EUPHAS Study Group: PMX endotoxin removal in the clinical practice: results from the EUPHAS trial. Contrib Nephrol 2010; 167: 83-90.
8. Cruz DN, de Cal M, Piccinni P, Ronco C: Polymyxin-B hemoperfusion and endotoxin removal: lessons from a review of the literature. Contrib Nephrol 2010; 167: 77-82.
9. Antonelli M, Bello G, Maviglia R, Cutuli SL, Ronco C, Cruz D, Ranieri VM, Martin EL, Fumagalli R, Monti G, Vesconi S, Casella G, Piccinni P, Debitonto M, Fasanella E, Monza G, Blasetti AG, Coletta R, D'Ambrosio M, Cinnella G, Mattei A, Piscitelli E, Centonze G, Cucurachi M, Altieri G, Del Rosso G, Polidoro M, Mani RK, Stigliano N, De Trana L, Pittella G, Paternoster G, Caione R, Puscio D, Singh O, Pulito G, Idra AS, Sathe P, Congolani D, Falzetti G, Vecchiarelli P, Giunta F, Forfori F, Castiglione G, Nangia V, Madonna R, Urbano C, Pezza B, Sachin G, D'Costa PM, Capra C, Crema L, Tamayo L, Srivanas S, Singh YP; Early Use of Polymyxin B Hemoperfusion in the Abdominal Sepsis 2 Collaborative Group: Polymyxin B hemoperfusion in clinical practice: the picture from an unbound collaborative registry. Blood Purif 2014; 37(suppl 1):22-25.
10. Ronco C, Klein DJ: Polymyxin B hemoperfusion: a mechanistic perspective. Crit Care 2014; 18: 309.